Stock futures are up modestly, reflecting sentiment from Monday’s record closes on easing trade tensions and a looming Federal Reserve policy meeting. Investor optimism is supported by a newly forged U.S.-EU trade framework that halves tariffs to 15% and eases geopolitical worries. U.S.-China trade talks are also underway in Stockholm, with officials seeking to extend the existing tariff truce another 90 days.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Oil prices have risen by about 1%, with Brent near $70.50, as President Trump accelerated a timeline for sanctions on Russian oil. Gold dipped slightly to a three-week low amid a firmer dollar and shrinking risk premium.
This week’s schedule is event heavy. Investors are watching for earnings from megacaps Meta, Microsoft, Amazon and Apple later in the week. On the macro front, JOLTS job openings, consumer confidence, ADP payrolls, GDP estimates, and Fed commentary carry high potential to reset expectations.
In pre-market trading, S&P 500 futures rose 0.22%, Nasdaq futures rose 0.44% and Dow futures rose 0.08%
Check out this morning’s top movers from around Wall Street, compiled by The Fly and subscribe to the daily Fly By on YouTube.
HIGHER –
- Sarepta (SRPT) up 37% after the FDA notified the company that it may lift its voluntary pause on shipments of ELEVIDYS for ambulatory patients with Duchenne
UP AFTER EARNINGS –
DOWN AFTER EARNINGS –
- Royal Caribbean (RCL) down 6%
- Spotify (SPOT) down 6%
- Merck (MRK) down 4%
- PayPal (PYPL) down 4%
- Johnson Controls (JCI) down 3%
- UnitedHealth (UNH) down 2%
- UPS (UPS) down 2%
- Sysco (SYY) down 2%
LOWER-
- Norfolk Southern (NSC) down 3% after announcing Union Pacific (UNP) will acquire the company in a stock and cash transaction, implying a value for Norfolk Southern of $320 per share
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on SRPT:
- Video: Boeing results, dealmaking highlight busy morning
- Sarepta price target raised to $15 from $11 at Piper Sandler
- Sarepta price target raised to $20 from $15 at Morgan Stanley
- Sarepta price target raised to $40 from $25 at BMO Capital
- Sell Rating for Sarepta Therapeutics Amidst Uncertainty and Financial Risks